Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Language
Publication year range
1.
FEMS Immunol Med Microbiol ; 55(2): 240-9, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19159428

ABSTRACT

New methods are needed to eradicate or prevent Chlamydia trachomatis infections. Blockade of epithelial membrane protein 2 (EMP2) by genetic silencing or neutralizing polyclonal antibody reduced chlamydial infectivity in vitro. This study tests the prediction that recombinant anti-EMP2 diabody could reduce early chlamydial infection of the genital tract in vivo. In a murine infection model, pretreatment with anti-EMP2 diabody, as compared with control diabody, significantly reduced bacterial load, tissue production of inflammatory cytokines, recruitment of polymorphonuclear leukocytes, and local tissue inflammation. These findings support EMP2 as a potential preventative and therapeutic target for genital chlamydial infection.


Subject(s)
Chlamydia Infections/prevention & control , Chlamydia muridarum/immunology , Genital Diseases, Female/prevention & control , Immunoglobulins/therapeutic use , Membrane Glycoproteins/antagonists & inhibitors , Animals , Chlamydia Infections/immunology , Chlamydia Infections/microbiology , Chlamydia Infections/pathology , Colony Count, Microbial , Cytokines/immunology , Cytokines/metabolism , Female , Genital Diseases, Female/immunology , Genital Diseases, Female/microbiology , Genital Diseases, Female/pathology , Immunoglobulins/genetics , Inflammation/immunology , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Mice , Mice, Inbred BALB C
2.
Clin Cancer Res ; 14(22): 7367-77, 2008 Nov 15.
Article in English | MEDLINE | ID: mdl-19010852

ABSTRACT

PURPOSE: Endometrial cancer is the most common gynecologic malignancy. One promising biomarker is epithelial membrane protein 2 (EMP2), and its expression is an independent prognostic indicator for tumors with poor clinical outcome expression. The present study assesses the suitability of EMP2 as a therapeutic target. EXPERIMENTAL DESIGN: Human monovalent anti-EMP2 antibody fragments were isolated from a human phage display library and engineered as bivalent antibody fragments (diabodies) with specificity and avidity to both EMP2 peptides and native cell-surface EMP2 protein. Diabodies were assessed using cell death and apoptosis assays. In addition, the efficacy of EMP2 diabodies on endometrial cancer tumors was determined using mouse xenograft models. RESULTS: Treatment of human endometrial adenocarcinoma cell lines with anti-EMP2 diabodies induced significant cell death and caspase-3 cleavage in vitro. These responses correlated with cellular EMP2 expression and were augmented by progesterone, which physiologically induces EMP2 expression. In vivo, treatment of subcutaneous human xenografts of HEC-1A cell lines with anti-EMP2 diabodies suppressed tumor growth and induced cell death in the xenograft. CONCLUSIONS: These findings suggest that EMP2 may be a potential pharmacologic target for human endometrial cancer.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/pharmacology , Endometrial Neoplasms/metabolism , Immunoglobulin Fragments/pharmacology , Membrane Glycoproteins/antagonists & inhibitors , Neoplasms, Experimental/drug therapy , Animals , Antibody Specificity , Apoptosis/drug effects , Cell Line, Tumor , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Humans , Immunohistochemistry , Membrane Glycoproteins/immunology , Mice , Mice, Nude , Xenograft Model Antitumor Assays
3.
Ocul Immunol Inflamm ; 16(1): 51-3, 2008.
Article in English | MEDLINE | ID: mdl-18379944

ABSTRACT

Tubulointerstitial nephritis and uveitis (TINU) generally occurs at young age and has a female preponderance. Renal biopsy reveals interstitial infiltration of inflammatory cells and edema, and the associated intraocular inflammation typically consists of an anterior, bilateral uveitis. The pathogenesis of TINU likely involves both humoral and cellular immunity and is mediated by medications, infectious agents, or other unknown causes. A previous report detected a renal antigen recognized by the serum of a TINU patient. In this report the authors extend these observations to document seroreactivity against a retinal antigen of similar size.


Subject(s)
Antigens/immunology , Autoimmunity , Kidney/immunology , Nephritis, Interstitial/immunology , Retina/immunology , Uveitis/immunology , Adolescent , Blood-Retinal Barrier , Fluorescein Angiography , Humans , Nephritis, Interstitial/physiopathology , Syndrome , Uveitis/physiopathology
4.
J Neuroophthalmol ; 28(1): 5-11, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18347451

ABSTRACT

BACKGROUND: Anti-retinal antibodies have been described in the context of autoimmune retinopathies and are often presumed to be pathogenic or disease associated. However, full characterization of patterns of anti-retinal antibody reactivity in normal human serum has been limited. The purpose of this work was to identify the profile of anti-retinal IgG antibodies in serum used as controls in laboratory testing. METHODS: Normal human sera used in commercial diagnostic laboratories were tested for the presence of immunoreactivity against soluble human retinal proteins using Western blot analysis of fractionated soluble human retinal proteins. Reactivity was quantified using computerized densitometry, and the level of reactivity was standardized relative to a control positive serum with known reactivity against recoverin. RESULTS: Some anti-retinal reactivity was observed in the majority of all tested normal sera. Reactivity against one to two protein bands was observed in 33%. Reactivity against five or more distinct bands was observed in 22%. There was a tendency for serum from women to react with three or more protein bands compared with serum from men. CONCLUSIONS: The presence of anti-retinal antibodies is observed in a majority of normal control human sera, suggesting that identification of new candidate retinal autoantigens should be cautiously interpreted and subject to rigorous testing for disease association. Additional studies will aid development of a standardized protocol for validation of potential pathogenic seroreactivity.


Subject(s)
Autoantibodies/blood , Retina/immunology , Retinal Diseases/immunology , Adolescent , Adult , Aged , Autoantigens/immunology , Eye Proteins/immunology , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Recoverin/immunology , Reference Values , Reproducibility of Results , Retinal Diseases/diagnosis , Sex Characteristics
5.
J Biol Chem ; 282(36): 26542-51, 2007 Sep 07.
Article in English | MEDLINE | ID: mdl-17609206

ABSTRACT

Caveolin-1 is the primary component of caveolae and functions in a variety of intracellular activities, including membrane trafficking and signal transduction. EMP2 (epithelial membrane protein 2) is a tetraspan protein recently identified as a novel regulator of caveolin-1 expression. In this study, we analyzed the mechanism of EMP2-mediated caveolin-1 regulation. In NIH 3T3 cells and in the human retinal pigment epithelium cell line (ARPE-19), EMP2 regulates caveolin-1 transcription and more substantially its protein levels. EMP2-mediated down-regulation of caveolin-1 does not affect caveolin-1 translational efficiency, phosphorylation, or proteasome-mediated degradation. Analysis of caveolin-1 protein half-life indicates the EMP2-mediated loss of caveolin-1 occurs rapidly. Protease inhibition and laser confocal microscopy associates this fate with specific intracellular compartmentalization, including early lysosomal delivery. These findings elucidate a new mechanism of caveolin-1 regulation and define an additional role for EMP2 as a key regulator of cell membrane composition.


Subject(s)
Caveolin 1/biosynthesis , Membrane Glycoproteins/metabolism , Pigment Epithelium of Eye/metabolism , Protein Processing, Post-Translational/physiology , Transcription, Genetic/physiology , Animals , Caveolin 1/genetics , Cell Membrane/genetics , Cell Membrane/metabolism , Down-Regulation/physiology , Humans , Lysosomes/genetics , Lysosomes/metabolism , Membrane Glycoproteins/genetics , Mice , NIH 3T3 Cells , Phosphorylation , Pigment Epithelium of Eye/cytology , Proteasome Endopeptidase Complex/metabolism , Proteasome Inhibitors , Protein Transport/physiology
6.
Microbes Infect ; 9(8): 1003-10, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17544801

ABSTRACT

Chlamydiae are bacterial pathogens which have evolved efficient strategies to enter, replicate, and survive inside host epithelial cells, resulting in acute and chronic diseases in humans and other animals. Several candidate molecules in the host receptor complex have been identified, but the precise mechanisms of infection have not been elucidated. Epithelial membrane protein-2 (EMP2), a 4-transmembrane protein, is highly expressed in epithelial cells in sites of chlamydial infections. Here we show that infectivity of the Chlamydia muridarum (MoPn) is associated with host cellular expression of EMP2 in multiple cell lines. Recombinant knockdown of EMP2 impairs infectivity, whereas infectivity is augmented in cells recombinantly modified to over-express EMP2. An epithelial cell line without native expression of EMP2 is relatively resistant to MoPn infection, whereas infectivity is markedly increased by recombinant expression of EMP2 in that cell line. Blockade of surface EMP2 using a specific anti-EMP2 antibody significantly reduces chlamydial infection efficiency. In addition, MoPn infectivity as measured in the EMP2 overexpressing cell line is not heparin-dependent, suggesting a possible role for EMP2 in the non-reversible phase of early infection. These findings identify EMP2 as a candidate host protein involved in infection of C. muridarum (MoPn).


Subject(s)
Chlamydia muridarum/pathogenicity , Epithelial Cells/metabolism , Membrane Glycoproteins/immunology , Membrane Glycoproteins/metabolism , Amino Acid Sequence , Cell Line , Epithelial Cells/immunology , Humans , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Molecular Sequence Data , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
7.
Doc Ophthalmol ; 113(2): 123-32, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16972082

ABSTRACT

BACKGROUND: Multiple sclerosis (MS) has been associated with inflammation of the uveal tract, suggesting an immunological link between the uvea and central nervous system (CNS) in this disease. The retina is embryologically derived from the CNS, and it is conceivable that retinal antigens may also be recognized by the immune system in MS. Electroretinographic abnormalities, as well as retinal autoantibodies, have previously been described in MS. We performed this study to further explore the possibility of retinal autoimmunity in MS. METHODS: Thirty-four patients with clinically definite MS and thirty-seven healthy controls were recruited. All patients and controls had standard electroretinographic (ERG) testing done, as well as a brightflash ERG protocol to isolate rod photoreceptor function. Patient and control sera were analyzed for the presence of antiretinal antibodies using Western blot techniques. RESULTS: We found statistically significant differences between MS patients and controls in four ERG parameters. In the MS group, implicit times of the rod-cone b-wave response, cone b-wave response, and rod photoreceptor response were increased. The amplitudes of the photopic oscillatory potentials were reduced in the MS group. Patients with the highest titres of retinal autoantibodies had delayed rod-cone b-wave implicit times and diminished photopic oscillatory potential amplitudes. CONCLUSIONS: We report ERG evidence of retinal dysfunction in patients with MS. We also report the first use of the brightflash ERG protocol in MS, which demonstrated rod photoreceptor dysfunction. Patients with the highest antiretinal antibody titres had abnormal ERG recordings. Retinal autoimmunity is a possible explanation for these observed ERG abnormalities in MS patients.


Subject(s)
Autoantibodies/immunology , Multiple Sclerosis/physiopathology , Retinal Cone Photoreceptor Cells/immunology , Retinal Diseases/immunology , Retinal Rod Photoreceptor Cells/immunology , Adult , Blotting, Western , Disease Progression , Electroretinography , Female , Follow-Up Studies , Humans , Male , Multiple Sclerosis/complications , Multiple Sclerosis/immunology , Prognosis , Retinal Cone Photoreceptor Cells/physiopathology , Retinal Diseases/etiology , Retinal Diseases/physiopathology , Retinal Rod Photoreceptor Cells/physiopathology
8.
Proceedings. Biological sciences / The Royal Society ; 272(1577): 2181-2188, Oct. 2005. graf
Article in English | MedCarib | ID: med-17650

ABSTRACT

Regardless of their origins, mate preferences should, in theory, be shaped by their benefits in a mating context. Here we show that the female preference for carotenoid colouration in guppies (Poecilia reticulata) exhibits a phenotypically plastic response to carotenoid availability, confirming a key prediction of sexual selection theory. Earlier work indicated that this mate preference is genetically linked to, and may be derived from, a sensory bias that occurs in both sexes: attraction to orange objects. The original function of this sensory bias is unknown, but it may help guppies find orange-coloured fruits in the rainforest streams of Trinidad. We show that the sensory bias also exhibits a phenotypically plastic response to carotenoid availability, but only in females. The sex-specificity of this reaction norm argues against the hypothesis that it evolved in a foraging context. We infer instead that the sensory bias has been modified as a correlated effect of selection on the mate preference. These results provide a new type of support for the hypothesis that mate preferences for sexual characters evolve in response to the benefits of mate choice--the alternatives being that such preferences evolve entirely in a non-mating context or in response to the costs of mating.


Subject(s)
Animals , Male , Female , Sexuality , Phenotype , Sexual Behavior, Animal , Carotenoids , Poecilia/genetics , Poecilia/metabolism , Poecilia/physiology , Trinidad and Tobago
9.
Proc Biol Sci ; 272(1577): 2181-8, 2005 Oct 22.
Article in English | MEDLINE | ID: mdl-16191629

ABSTRACT

Regardless of their origins, mate preferences should, in theory, be shaped by their benefits in a mating context. Here we show that the female preference for carotenoid colouration in guppies (Poecilia reticulata) exhibits a phenotypically plastic response to carotenoid availability, confirming a key prediction of sexual selection theory. Earlier work indicated that this mate preference is genetically linked to, and may be derived from, a sensory bias that occurs in both sexes: attraction to orange objects. The original function of this sensory bias is unknown, but it may help guppies find orange-coloured fruits in the rainforest streams of Trinidad. We show that the sensory bias also exhibits a phenotypically plastic response to carotenoid availability, but only in females. The sex-specificity of this reaction norm argues against the hypothesis that it evolved in a foraging context. We infer instead that the sensory bias has been modified as a correlated effect of selection on the mate preference. These results provide a new type of support for the hypothesis that mate preferences for sexual characters evolve in response to the benefits of mate choice--the alternatives being that such preferences evolve entirely in a non-mating context or in response to the costs of mating.


Subject(s)
Carotenoids/metabolism , Color Perception/physiology , Pigmentation/physiology , Poecilia/physiology , Selection, Genetic , Sexual Behavior, Animal/physiology , Analysis of Variance , Animals , Body Constitution , Body Size , Female , Poecilia/genetics , Poecilia/metabolism , Sex Factors , Trinidad and Tobago
SELECTION OF CITATIONS
SEARCH DETAIL
...